Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study
Introduction In 2006, the first human papillomavirus (HPV) vaccine was approved by the Food and Drug Administration in the USA based on pre-licensure clinical trials that found it to be highly efficacious at preventing persistent infection and precancerous, high-grade cervical lesions (HGCLs) caused...
Saved in:
| Main Authors: | Carlos R Oliveira, Anette Michelle Ortiz, Sangini S Sheth, Eugene D Shapiro, Linda M Niccolai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/4/e043093.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathways and processes to adopting or switching to a single-dose HPV vaccination schedule in low- and middle-income countries: a qualitative study.
by: Sunny Roy, et al.
Published: (2025-01-01) -
Treatment and Prevention of HPV-Associated Skin Tumors by HPV Vaccination
by: Thomas Meyer, et al.
Published: (2024-12-01) -
Determining the Knowledge Levels of University Students About HPV and HPV Vaccine
by: Ayşe Dost, et al.
Published: (2024-12-01) -
Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
by: François Coutlée, et al.
Published: (2020-08-01) -
Mathematical Model of Human Papillomavirus (HPV) Dynamics With Double-Dose Vaccination and Its Impact on Cervical Cancer
by: Henok Desalegn Desta, et al.
Published: (2024-01-01)